289 related articles for article (PubMed ID: 10406547)
1. Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits.
Douma CE; Zweers MM; de Waart DR; van der Wardt AB; Krediet RT; Struijk DG
Perit Dial Int; 1999; 19 Suppl 2():S358-64. PubMed ID: 10406547
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-related experiments on peritoneal solute transport in the rabbit.
Struijk DG; Douma CE; Krediet RT; Zweers MM
Nephrol Dial Transplant; 2001 Mar; 16(3):661-3. PubMed ID: 11239062
[TBL] [Abstract][Full Text] [Related]
3. The standard peritoneal permeability analysis in the rabbit: a longitudinal model for peritoneal dialysis.
Zweers MM; Douma CE; de Waart DR; van der Wardt AB; Ho-dac-Pannekeet MM; Krediet RT; Struijk DG
Perit Dial Int; 1999; 19(1):56-64. PubMed ID: 10201342
[TBL] [Abstract][Full Text] [Related]
4. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD.
Douma CE; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1997 Jun; 51(6):1885-92. PubMed ID: 9186879
[TBL] [Abstract][Full Text] [Related]
5. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
Douma CE; de Waart DR; Struijk DG; Krediet RT
Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
[TBL] [Abstract][Full Text] [Related]
6. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
Smit W; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
[TBL] [Abstract][Full Text] [Related]
8. Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis?
Douma CE; de Waart DR; Struijk DG; Krediet RT
J Lab Clin Med; 1998 Oct; 132(4):329-40. PubMed ID: 9794705
[TBL] [Abstract][Full Text] [Related]
9. [Effects of nitroprusside and vibration on peritoneal transport of solutes in continuous ambulatory peritoneal dialysis patients].
Tan XY; Liu FY; Duan SB
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):357-60. PubMed ID: 12206001
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B, mercury chloride and peritoneal transport in rabbits.
Zweers MM; Douma CE; de Waart DR; Korevaar JC; Krediet RT; Struijk DG
Clin Nephrol; 2001 Jul; 56(1):60-8. PubMed ID: 11499660
[TBL] [Abstract][Full Text] [Related]
11. Does the biocompatibility of the peritoneal dialysis solution matter in assessment of peritoneal function?
Parikova A; Struijk DG; Zweers MM; Langedijk M; Schouten N; van den Berg N; Duis S; Krediet RT
Perit Dial Int; 2007; 27(6):691-6. PubMed ID: 17984433
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
Davenport A; Fernando RL; Varghese Z
Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
[TBL] [Abstract][Full Text] [Related]
13. A quantitative description of solute and fluid transport during peritoneal dialysis.
Heimbürger O; Waniewski J; Werynski A; Lindholm B
Kidney Int; 1992 May; 41(5):1320-32. PubMed ID: 1614047
[TBL] [Abstract][Full Text] [Related]
14. Augmented peritoneal mass transport with intraperitoneal nitroprusside.
Hirszel P; Maher JF; Chamberlin M
J Dial; 1978; 2(2):131-42. PubMed ID: 681579
[TBL] [Abstract][Full Text] [Related]
15. Addition of a nitric oxide inhibitor to a more biocompatible peritoneal dialysis solution in a rat model of chronic renal failure.
de Graaff M; Vlijm A; Zweers MM; Coester AM; Vandemaele F; Struijk DG; Krediet RT
Adv Perit Dial; 2010; 26():7-11. PubMed ID: 21348371
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral administration of losartan, prazosin, and verapamil on peritoneal solute transport in continuous ambulatory peritoneal dialysis patients.
Rojas-Campos E; Cortés-Sanabria L; Martínez-Ramírez HR; González L; Martín-del-Campo F; González-Ortiz M; Cueto-Manzano AM
Perit Dial Int; 2005; 25(6):576-82. PubMed ID: 16411525
[TBL] [Abstract][Full Text] [Related]
17. Daily exposure to dialysis fluid results in changes in peritoneal transport.
Wang T; Qureshi AR; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Perit Dial Int; 1997; 17(4):379-86. PubMed ID: 9284466
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
[TBL] [Abstract][Full Text] [Related]
19. Continuous flow peritoneal dialysis: assessment of fluid and solute removal in a high-flow model of "fresh dialysate single pass".
Freida P; Issad B
Perit Dial Int; 2003; 23(4):348-55. PubMed ID: 12968842
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal fluid transport in CAPD patients with different transport rates of small solutes.
Sobiecka D; Waniewski J; Weryński A; Lindholm B
Perit Dial Int; 2004; 24(3):240-51. PubMed ID: 15185772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
